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Background: In the breast, the pleiotropic epigenetic regulator HDAC7 can influence stemness. Mate-
rials & Methods: The authors used MCF10 cells knocked-out for HDAC7 to explore the contribution of
HDAC7 to IGF1 signaling. Results: HDAC7 buffers H3K27ac levels at the IGFBP6 and IGFBP7 genomic loci
and influences their expression. In this manner, HDAC7 can tune IGF1 signaling to sustain stemness. In
HDAC7 knocked-out cells, RXRA promotes the upregulation of IGFBP6/7 mRNAs. By contrast, HDAC7 in-
creases FABP5 expression, possibly through repression of miR-218. High levels of FABP5 can reduce the
delivery of all-trans-retinoic acid to RXRA. Accordingly, the silencing of FABP5 increases IGFBP6 and IGFBP7
expression and reduces mammosphere generation. Conclusion: The authors propose that HDAC7 controls
the uptake of all-trans-retinoic acid, thus influencing RXRA activity and IGF1 signaling.
First draft submitted: 7 September 2020; Accepted for publication: 17 March 2021; Published online:
21 April 2021
Keywords: breast • ChIP-seq • CRABP2 • FABP5 • HDAC7 • IGF1 • MEF2 • miR-218 • retinoids • stemness
HDAC7 belongs to the class IIa HDAC family, which includes pleiotropic epigenetic regulators. HDAC7 plays
important roles in several differentiation decisions and adaptive responses in adults [1,2]. This class IIa member is
abundantly expressed in the breast, where it plays a part in the control of proliferation and in the morphogenetic
process. These actions are instrumental in allowing acini formation in vitro [3,4].
The microenvironment plays a key role in sculpting the epigenome to maintain tissue homeostasis [5]. Its action
influences different cell populations, including the pool of tissue-specific stem cells. Specifically, the microenviron-
ment modulates the regenerative capabilities of stem cells by influencing the activity of several signaling pathways
that control stem cell behavior [6].
HDAC7 can also regulate stem cell functions, particularly in the breast. Its actions are mediated at the level of
both the microenvironment and intrinsic stemness program regulation [7–10]. Several secreted factors that create and
sculpt the microenvironment are under the repressive action of HDAC7 [9]. The microenvironment is fundamental
in supervising and maintaining breast stem cell properties. Deletion of HDAC7 unleashes the expression of negative
regulators of stemness, such as IL-24, and dramatically impairs mammosphere generation [9,11].
IGF1 is an important determinant of mammary terminal end bud and ductal formation during development [12].
In addition, IGF1 plays significant roles in breast cancer development, progression and metastasis [13]. IGF1 signaling
is finely tuned through a complex network of signaling molecules, which comprise IGFBPs, IGF1R and specific
transducers. IGF1 is implicated in breast cancer development, and IGF1R signaling contributes to breast cancer
stem cell maintenance [14,15]. IGFBP6 and IGFBP7 are among the genes regulated by HDAC7 in breast cells [9].
However, how HDAC7 can regulate their expression and whether epigenetic status at the IGFBP6 and IGFBP7
loci is modulated by HDAC7 are currently unknown. For these reasons, the authors, in this study, investigated
additional mechanisms engaged by HDAC7 in the maintenance of stemness in MCF10A mammary epithelial cells.
The authors dissected the regulation driven by HDAC7 to control the expression of IGFBP6 and IGFBP7, two
additional putative anti-stem factors capable of influencing IGF1 signaling.
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Methods
Cell cultures & reagents
MCF10A cells were grown as previously described [4]. HEK293T and AMPHO cells were grown in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum. MCF10A/HDAC7−/− cells and the
same cells expressing the inducible form of HDAC7 were grown in complete F12/DMEM medium without phenol
red (Sigma-Aldrich, MO, USA) and with 5% charcoal-stripped horse serum [9], and 4-OHT (Sigma-Aldrich) was
used at 1 μM. In all media, L-glutamine (2 mM), penicillin (100 U/ml) and streptomycin (100 μg/ml) (Euroclone,
Milan, Italy) were added.
Mammosphere assays
Mammospheres were grown in mammosphere medium composed of Ham’s F12/DMEM 1:1 medium (Sigma-
Aldrich) supplemented with B27 (1x, Gibco, MA, USA) and EGF (20 ng/ml, PeproTech, London, UK). Next,
1 × 103 trypan blue-negative cells were seeded in ultra low-attachment multiwells (Corning, NY, USA) and
cultivated for 10 days. For IGF1 (20 ng/ml) (PeproTech) treatments, MCF10A cells were pre-treated for 2 days.
For the evaluation of FABP5 silencing and miR-21 and miR-218 mimicking effects on mammosphere formation,
interfering RNAs were delivered using Lipofectamine 2000 (ThermoFisher, MA, USA). After 24 h, cells were
harvested and cultured for 5 days in ultra low-attachment plates. The efficiency of the interference was evaluated
using parallel cultures after 72 h of silencing. Images were collected with a Leica AF 6000LX microscope (Leica
Microsystems, Mannheim, Germany). Spheres over 50 μm in diameter were counted. Area was measured with
ImageJ software as previously described [16].
Immunofluorescence, immunoprecipitation & immunoblotting
After transfection, HEK293 cells were fixed with 3% paraformaldehyde and permeabilized with 0.1% Triton
X-100 (Sigma-Aldrich). Immunofluorescence was performed using anti-FLAG M2 antibody. The secondary an-
tibodies were Alexa Fluor 546-conjugated goat anti-mouse antibodies (A-11030; Thermo Fisher Scientific). Cells
were imaged with a Leica confocal scanner SP2 microscope equipped with a 488-λ argon laser and a 543–633-λ
helium–neon laser. For co-immunoprecipitation, cells were lysed in a hypotonic buffer (20 mM Tris-HCl, pH 7.5;
10 mM MgCl2; 10 mM KCl; and 1% Triton X-100) supplemented with protease and phosphatase inhibitors.
For each immunoprecipitation, 1 μg of anti-HDAC7 or anti-GFP antibodies was used. Protein complexes were
collected with Protein A Sepharose beads and processed for SDS-page (Merck KGaA, Darmstadt, Germany) [17].
For immunoblotting, cell lysates after SDS-PAGE and immunoblotting were incubated with primary antibodies
as previously described [17]. Secondary antibodies were obtained from Sigma-Aldrich (peroxidase-conjugated goat
anti-rabbit IgG A05451 and peroxidase-conjugated goat anti-mouse IgG A4416), and blots were developed with
SuperSignal west dura (Pierce, MA, USA).
Antibodies
The primary antibodies used were against MEF2D (610774; BD Biosciences, CA, USA), actin (A2066; Sigma-
Aldrich), FLAG M2 (F1804; Sigma-Aldrich), GFP and HDAC4 [18], HDAC7 [9], RXR alpha (D-20; Santa Cruz
Biotechnology, TX, USA), H3K27ac (ab4729; Abcam, MA, USA), CRABP2 (sc-166897; Santa-Cruz Biotechnol-
ogy) and FABP5 (sc-365236; Santa-Cruz Biotechnology).
Plasmid transfection, siRNA delivery & luciferase assay on FABP5 3′UTR
The generation of the pEGFP-N1-MEF2D plasmid was previously described [17]. The CDS of RXRA
(NM 002957) and CDS of USP33 (NM 015017) were cloned in pEGFP N1 using a PCR/restriction-based
method (RXRA forward [FW]: AAAGAATTCCTAAGTCATTTGGTGCGG, reverse [RV]: AAAAGATCTATG-
GACACCAAACATTTCC; USP33 FW: GGCGGATCCATGACAGGATCAAATTCACAC, RV: AAAGGATC-
CAACAAAGACCGAGTTTCTACTTGAA), and pFLAG CMV5a HDAC7 was obtained by subcloning the CDS
of HDAC7 (NM 015401) from pWZL HDAC7 GFP [19]. The 205-bp-long 3′UTR of FABP5 was cloned in pGL3
control by means of a PCR/restriction-based method using 50 ng of gDNA extracted from MCF10A cells as a tem-
plate and primers bearing the restriction sites of XbaI (FW: AAATCTAGAGTAAATTCCATCATCACTTTGG,
RV: AAATCTAGAAGCACAAACACATTTATTTATTA).
For silencing and delivery of miRNA mimics, 74 pmol of siRNA duplex against RXRA (GGGA-
GAAGGUCUAUGCGUC), FOXA1 (CCAUGAACACCUACAUGACCAUG), FABP5 (GUGCAUUGGU-
684 Epigenomics (2021) 13(9) future science group
HDAC7 represses IGFBP6 & IGFBP7 expression to sustain mammary stemness Research Article
UCAGCAUCA), miR-21 (HMI0371) and miR-218 (HMI0384) was delivered to MCF10A cells using Lipo-
fectamine 2000 as a transfection reagent. Equal amounts of scramble control siRNA ware used as a control
(UAAGGCUAUGAAGAGAUAC; Sigma-Aldrich).
For luciferase assay, 1 μg of pGL3 control or pGL3 control 3′UTR FABP5 and 100 ng of pRenilla were
transfected in MCF10A HDAC7+/+ and HDAC7−/− cells. After 48 h, cells were lysed and processed using the
Dual-Luciferase reporter assay system (Promega, WI, USA).
RNA extraction & quantitative real-time PCR
Cells were lysed using TRI Reagent (Molecular Research Center, OH, USA). Next, 1.0 μg of total RNA was
retrotranscribed using 100 units of M-MLV reverse transcriptase (Life Technologies, MA USA). Quantitative
real-time PCR (qRT-PCR) was performed using SYBR green technology (Kapa Biosystems, MA, USA). Data were
analyzed by comparative threshold cycle using HPRT and GAPDH as normalizers.
RNA expression array & data analysis
RNA expression experiments were performed as previously described [9]. Fold change and p-values for each probe
set were calculated using a moderated t-statistic in the limma package [20], with the variance estimate being adjusted
by incorporating global variation measures for the complete set of probes on the array. All p-values were then
corrected for multiple hypothesis testing using the Benjamini–Hochberg method. Differentially expressed genes
were selected based on fold changes and adjusted p < 0.05.
Chromatin immunoprecipitation, library construction, chromatin immunoprecipitation sequencing
& next-generation sequencing data analysis
For chromatin immunoprecipitation sequencing (ChIP-seq) experiments, 50 μg of chromatin was immunopre-
cipitated using 2 μg of anti-H3K27ac (ab4729; Abcam) or 6 μg of anti-HDAC7 antibody or control IgG. After
RNAseA treatment (Ambion, MA, USA) and de-crosslinking, DNA was purified with Zymo ChIP columns. Next,
5 ng of total DNA obtained by pulling three independent experiments was used to prepare ChIP-seq libraries
according to the TruSeq ChIP sample preparation guide (Illumina, CA, USA). Libraries were sequenced on the
Illumina HiSeq 2000 sequencer. Sequencing reads from ChIP-seq experiments were aligned to the National Center
for Biotechnology Information GRCh38 human reference with Bowtie 2 [21]. Peak heat maps, gene annotation
and the resulting Venn diagrams and bar plots representing peak localization in genomic elements/distance from
the transcription start site (TSS) were obtained using the ChIPseeker and Gviz R/Bioconductor packages [22–24].
Quantitative PCR was used to validate ChIP-seq data on the IGFBP6 and IGFBP7 loci using the primers IGFBP6
TSS FW: TCCAGTCCCACCCAGTTTAG, RV: GGTCATGGTCAGGGTTTGTG; IGFBP7 INTRON1 FW:
AGCCAGGATTCAGGGTAGGT, RV: GAGACCCTGTGTTGGGCTAA; and IGFBP7 TSS FW: CTTTACC-
CTTCCGCCTCTTG, RV: CTCTTCCTCCTCTTCGGACA.
In silico miRNA target analysis
The authors queried the TarBase v8 database (https://carolina.imis.athena-innovation.gr/diana tools/web/index.p
hp?r=tarbasev8%2Findex) to identify miRNAs that were validated as regulators of the FABP5 gene. The authors
queried five databases of miRNA predicted targets, miRWalk (http://mirwalk.umm.uni-heidelberg.de/), TargetScan
(www.targetscan.org/vert 72/), miRDB (http://mirdb.org/cgi-bin/search.cgi), miRSystem (http://mirsystem.cgm.
ntu.edu.tw/index.php) and miRmap (https://mirmap.ezlab.org/app/), retaining the results confirmed by at least
four different approaches.
Detection of miRNA expression
For quantification of mature miRNA, stem–loop RT-PCR was performed in a manner similar to that used by Chen
et al. [25]. The first reverse transcription was performed using 0.25 μM specific primers (Table 1) and 1 μM random
hexamers (Promega). For quantitative PCR, a specific FW primer and a universal RV primer complementary to
the stem–loop were used. Normalization was performed with respect to U6.
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Table 1. Oligonucleotides used to analyze miRNA expression.
Oligo name Sequence 5′ to 3′

































FW: Forward; RT: Reverse transcription; RV: Reverse.
Statistical analysis
The Student’s t-test was used for the experimental data. Dunn’s multiple comparison test was applied in case of
multiple sampling. A p = 0.05 was chosen for the significance limit. Data in the figures are arithmetic means and
standard deviations from at least three independent biological experiments.
Results
HDAC7 influences the expression of elements of IGF1 signaling
Gene expression profile studies in human mammary gland epithelial MCF10A cells knocked out for HDAC7 have
revealed that some components of the IGF signaling pathway are under the regulation of this deacetylase [9]. The
authors decided to analyze in a comprehensive manner the mRNA levels of different elements regulating IGF1
signaling in HDAC7−/− and HDAC7+/+ cells. The authors validated the results using an inducible system of
HDAC7 recovery, represented by HDAC7−/− cells expressing HDAC7-ER fusion. As a control, HDAC7−/− cells
expressing ER alone were used. IGFBP6, IGFBP7, IGFL1 and IRS2 are the genes of the IGF signaling network whose
mRNA levels are significantly upregulated in the absence of HDAC7. By contrast, IGFL2 is significantly repressed
after the knockout of HDAC7, and this repression is attenuated upon reintroduction of HDAC7 (Figure 1A). The
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Chr13: 109740000–109800000 IRS2 locus H3K27ac
Chr12: 53080000–53120000 IGFBP6 locus H3K27ac



















































Figure 1. IGF1 signaling under HDAC7 regulation and its impact on mammosphere generation. (A) Histograms
illustrating fold changes in the expression levels of the different elements of the IGF pathway between the different
engineered MCF10A cells as indicated. (B) Immunoblot analysis of AKT phosphorylation in HDAC7+/+ and HDAC7−/−
MCF10A cells treated with IGF1. Cells were starved for 24 h and then treated for the indicated hours with IGF1
(20 ng/ml). Cellular lysates were generated and immunoblots were performed with the indicated antibodies. (C)
Scatter dot plot illustrating the number of mammospheres generated by HDAC7+/+ and HDAC7−/− MCF10A cells. In
the case of IGF1, cells were pretreated for 2 days with 15 ng/ml of IGF1 or pretreated and next maintained in a
medium containing IGF1 (+P). (D) Detailed view of H3K27ac tracks at the IRS2, IGFBP6 and IGFBP7 loci in HDAC7−/−
and HDAC7+/+ MCF10A cells. Gene structure and chromosomal location are shown, with the blue box highlighting
differences in the enriched peaks between the two cell lines. *p < 0.05; **p < 0.01; ***p < 0.005.
Chr: Chromosome; ER: Endoplasmic reticulum.
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original data are shown in Supplementary Table 1.
In MCF10A cells, and in breast cancer cells in general, HDAC7 influences multiple aspects of the transformation
process, including stemness efficiency. These actions are mediated at the level of the microenvironment and by
controlling intrinsic stemness programs [8–10]. Hence, the authors next investigated whether the influence of
HDAC7 on IGF1 signaling may be responsible for the stemness properties of MCF10A cells. When MCF10A
cells are grown in suspension, they can form spheres with low efficiency. This assay is commonly used to measure
the presence of stem-like cells [9]. In the absence of HDAC7, IGF signaling could be dampened by the increased
levels of IGFBP6 and IGFBP7 [26,27], and this inhibition could impact on mammosphere generation. In fact,
IGF1 signaling in MCF10A cells, as measured by levels of AKT phosphorylation, is reduced in the absence of
HDAC7 (Figure 1B). Accordingly, deletion of HDAC7 impairs mammosphere generation, and treatment with
IGF1 potentiates sphere formation in both HDAC7+/+ and HDAC7−/− cells (Figure 1C). However, even in the
presence of IGF1, HDAC7−/− cells exhibit a deficit in sphere formation that cannot be completely reversed by the
addition of IGF1. This deficit strongly suggests that HDAC7 can modulate additional intrinsic stemness programs.
Since the role of IGFL1 and IGFL2 is poorly defined in the context of IGF-signaling, the authors focused the
subsequent analysis on IGFBP6, IGFBP7 and IRS2. The authors investigated the status of histone H3 lysine 27
acetylation (H3K27ac) by re-analyzing ChIP-seq experiments recently performed on HDAC7−/− and HDAC7+/+
MCF10A cells. All three genes contain regions highly acetylated on H3K27, indicative of an open chromatin status
and active transcription (Figure 1D). In general, H3K27ac signals are increased in HDAC7−/− cells, although with
a different behavior. In the case of the IRS2 locus, there is an increase in H3K27ac peaks in the promoter region
close to the TSS and in the 3′ end of the first intron. IGFBP6 shows high levels of H3K27ac around the first exon
and in the first intron. In the absence of HDAC7, there is a slight increase in H3K27ac peaks. Finally, IGFBP7
shows a region highly enriched for H3K27ac within the first intron. In addition, there are less intense H3K27ac
peaks distributed throughout its length. Ablation of HDAC7 provokes an increase in H3K37ac peaks in the highly
acetylated region as well as in the less intensely acetylated regions. Curiously, a reduction in acetylation levels is also
observed in a small region, as highlighted by the red box.
Upregulation of H3K27ac levels at regulatory regions of IGFBP6/7 loci was confirmed by quantitative ChIP-
PCR analysis (Supplementary Figure 1A). By contrast, IGFL1 and IGFL2 loci were characterized by very low levels
of H3K27ac, and removal of HDAC7 did not modify this profile (Supplementary Figure 1B & C).
In summary, IGFBP6, IGFBP7 and IRS2 loci were characterized by the presence of an open chromatin marker,
indicative of active transcription. The presence of highly acetylated regions within these loci, even in HDAC7-
expressing cells, and the moderate increases observed in HDAC7 null cells indicated that this class IIa HDAC was
involved in buffering rather than switching off H3K27ac levels in these regions.
Identification of transcription factors involved in mediating the repressive influence of HDAC7 on
IGFBP6 & IGFBP7
The MEF2 family of transcription factors (TFs) are well-established partners of class IIa HDACs [2,28]. However, the
upregulation of IGFBP6 and IGFBP7 seems to be independent of MEF2 transcriptional activity [9]. To identify new
TFs that, under the influence of HDAC7, could regulate IGFBP6 and IGFBP7 transcription, the promoters (±5 kb
from TSS) of IGFBP6 and IGFBP7 were analyzed using the LASAGNA-Search and MEME-ChIP tools [29,30].
For four TFs (FOXA1, E2F6, JUN/FOS and RUNX1), the authors also identified ChIP-seq peaks in the GTRD
database (Figure 2A) [31]. When the analysis was extended to the first intron of both genes, ChIP-seq peaks
corresponding to PPARG, RXRA and TFAP2A were also found. The authors focused attention on RXRA and
FOXA1 since their binding sites tend to co-localize and could be involved in the co-regulation of IGFBP6 and
IGFBP7 expression (Figure 2B).
To prove the contribution of FOXA1 and RXRA, the authors silenced their expression by RNAi. In HDAC7+/+
cells, the mRNA levels of both IGFBPs were reduced after downregulation of FOXA1, whereas RXRA influenced
only IGFBP6 levels. Curiously, RXRA mRNA was augmented in FOXA1-silenced cells (Figure 2C). A different
result was observed in HDAC7−/− cells. FOXA1 was necessary for IGFBP6 upregulation but dispensable for
IGFBP7 upregulation. By contrast, RXRA was required for the upregulation of both IGFPBs. The efficiency of
RXRA silencing was also verified at the protein level (Supplementary Figure 2A).
In summary, RXRA seemed to be responsible for the upregulation of IGFBP6 and IGFBP7 expression after the
deletion of HDAC7. It is important to note that the binding sites for RXRA were relatively distant from regions
subject to variation in H3K27ac context. To clarify this point, the authors explored the possibility that RXRA might
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Figure 2. RXRA regulates IGFBP6 and IGFBP7 mRNA levels in HDAC7−/− MCF10A cells. (A) To evaluate the existence
of new transcription factors regulating IGFBP6 and IGFBP7 expression, the authors identified the predicted (LASAGNA
and MEME-ChIP) and biologically validated (GTRD) TFBSs located in the promoters (±5 kb from the TSS) and first
introns of IGFBP6 and IGFBP7. TFBSs were listed alphabetically by candidate TFBS name. ChIP-seq data allowed
confirmation of the binding of four transcription factors out of 17 predicted by at least one of the two bioinformatics
approaches. (B) Schematic representation of the IGFBP6 and IGFBP7 loci up to 48 kb away from the TSS. Putative
RXRA and FOXA1 binding sites are indicated according to GTRD data. (C) HDAC7+/+ and HDAC7−/− MCF10A cells
were transfected with siRNAs against RXRA or FOXA1, and after cell lysis, mRNA was extracted. The mRNA expression
levels of the indicated genes were measured by quantitative real-time PCR and indicated as mean ± SD (n = 3).
Significance was calculated with respect to the relative control RNAi-transfected cells unless indicated by the grafts.
(D) RXRA/FOXA1 binding sites and H3K27ac normalized tracks are shown for WT and HDAC7−/− MCF10A cells at the
IGFBP7 locus. Light blue lines evidence the chromatin looping between the RXRA site and the regulative region
characterized by variation in H3K27ac levels. (E) RXRA/FOXA1 binding sites and H3K27ac normalized tracks are
shown for wild-type and HDAC7−/− MCF10A cells at the IGFBP6 locus. Light blue lines evidence the chromatin looping
between the RXRA sites and the regulative region characterized by variation in H3K27ac levels. Hi-C data [32] were
used to represent the topologically associated domains within the IGFBP6 locus
(http://promoter.bx.psu.edu/hi-c/view.php).
*p < 0.05; **p < 0.01; ***p < 0.005.
SD: Standard deviation; TFBS: Transcription factor binding site; TSS: Transcription start site.








































































Figure 3. HDAC7 does not bind to RXRA. (A) Immunoblot
analysis of RXRA levels in HDAC7−/− compared with
HDAC7+/+ MCF10A cells. Actin was used as loading control.
(B) Extracts from MCF10A cells were immunoprecipitated
with 1 μg of anti-HDAC7 or anti-GFP antibodies as control.
Next, immunocomplexes were subjected to immunoblot
with the indicated antibodies. A total of 1/100 inputs have
been included. (C) HEK293 cells were transfected with 3 μg
of pFLAG-HDAC7 and 1.5 μg of pEGFP encoding for MEF2D,
RXRA or USP33 as control. After 48 h, FLAG fusions were
immunoprecipitated with 1 μg anti-FLAG antibody and
subjected to immunoblotting with the anti-GFP antibody.
After stripping, the filter was probed with anti-FLAG
antibody. A total of 1/100 inputs have been included. (D)
Immunofluorescence analysis of HEK293 cells transiently
expressing the indicated transgenes. Confocal images are
shown in pseudocolors. Scale bar = 50 μM.
*p < 0.05; **p < 0.01; ***p < 0.005.
IP: Immunoprecipitation.
influence H3K27ac levels at IGFBP6/7 loci through chromosome looping. Hi-C data from MCF10A cells [32] were
used to visualize the topologically associated domains as organized at the IGFBP6/7 loci. Hi-C data indicated that
the distal binding sites for RXRA lay within defined topologically associated domains, and thus a distal influence
on H3K27ac levels at the IGFBP6/7 loci by chromatin looping was possible (Figure 2D & E).
Finally, the authors also found that, similar to the two IGFBPs, upregulation of IRS2 in HDAC7−/− cells was
dependent on RXRA (Supplementary Figure 2B). In this case, analysis of ChIP-seq peaks in the GTRD database
revealed the binding of RXRA at the H3K27ac regulative regions of IRS2 (Supplementary Figure 2C). Overall,
similar to IGFBP6 and IGFBP7, IRS2 upregulation was under the control of RXRA.
RXRA does not bind HDAC7 & does not influence its nuclear import
HDAC7 could regulate RXRA activity through several mechanisms, including regulation of RXRA expression or
the possibility of direct binding to the TF to repress its transcriptional activity. To understand how HDAC7 could
affect RXRA activity, the authors first evaluated RXRA levels in WT and knockout cells (Figure 3A). Immunoblot
confirmed the qRT-PCR data in Figure 2C, thus excluding upregulation of this TF in HDAC7−/− cells. Next, the
authors evaluated whether HDAC7 and RXRA could form a complex that could explain the repressive influence
of HDAC7 on IGFBP6 and IGFBP7 transcription. Co-immunoprecipitation experiments demonstrated that
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RXRA and HDAC7 did not interact in MCF10A cells. By contrast, and as expected [33], complexes between
HDAC7 and MEF2D were detected (Figure 3B). The absence of interaction was confirmed in HEK293 cells after
overexpression of HDAC7 and RXRA (Figure 3C). Finally, immunofluorescence analysis also evidenced a profound
difference between MEF2D and RXRA in the ability to interact with HDAC7. In fact, only the co-expression of
MEF2D promoted the nuclear accumulation of HDAC7 (Figure 3D).
HDAC7 indirectly controls RXRA activity
The authors reasoned that HDAC7 could indirectly affect RXRA transcriptional activity. RXRA is a partner of
different TFs via heterodimerization [34]. Moreover, retinoic acids undergo a dedicated cytosol/nuclear transport
and specific metabolism [35]. To find alternative mechanisms that could explain the repressive influence of HDAC7
on RXRA, the authors compared the expression levels of several RXRA partners and several genes controlling
retinoid transport/metabolism between HDAC7+/+ and HDAC7−/− cells (Figure 4A). Only the expression of
FABP5, CRABP2 and the pseudogene FABP5L2, with unknown functions, was significantly downregulated in
MCF10A/HDAC7−/− cells, and expression returned after HDAC7 restoration. FABP5 and CRABP2 encode for
two high-affinity all-trans-retinoic acid (atRA) binding proteins [35]. The downregulation of FABP5 and CRABP2
was confirmed by qRT-PCR (Figure 4B) and immunoblot (Figure 4D). Importantly, whereas FABP5 expression
was dramatically repressed, the expression of CRABP2 was only modestly affected. As a consequence, the ratio
between the mRNAs of the two atRA binding proteins was profoundly modified by the absence of HDAC7, and
this change could influence RXRA activity (Figure 4C). FABP5 was also downregulated at the protein level in the
absence of HDAC7 and upregulated after HDAC7 re-expression (Figure 4D).
To further support the role of the HDAC7/FABP5/RXRA/IGFBP circuit in mammosphere formation, the
authors silenced FABP5 expression in both HDAC7−/− and HDAC7+/+ cells to assess the level of IGFBP6/7
mRNAs (Figure 4E & F). Downregulation of FABP5 mRNA triggered the upregulation of IGFBP6/7 expression
(Figure 4E), confirming the hypothesized circuit. Importantly, sphere generation was reduced in both HDAC7−/−
and HDAC7+/+ cells. The number of mammospheres was reduced (Figure 4H), as was their size (Figure 4I), thus
indicating the role of FABP5 in regulating division and survival in MCF10A cells.
HDAC7 regulates the expression of miRNAs that could control FABP5 levels
The dramatic downregulation of FABP5 mRNA in cells null for HDAC7 suggested that this deacetylase was
necessary to sustain FABP5 transcription. To confirm this hypothesis, the authors compared the levels of H3K27ac
between WT and knockout cells at the FABP5 locus (Figure 4D). The FABP5 locus showed a certain level of
H3K27ac symptomatic of an actively transcribed gene. However, a reduction in the acetylation status was not
observed in the absence of HDAC7.
An alternative hypothesis to explain the HDAC7-dependent downregulation of FABP5 mRNA could be the
existence of specific miRNAs regulated by HDAC7 and able to target FABP5. As a first step in validating this
hypothesis, the authors isolated the 3′ untranslated region of FABP5 and compared its stability in HDAC7−/− and
HDAC7+/+ cells. A Dual-Luciferase assay showed that the 3′UTR of FABP5 was much less stable in cells deleted for
HDAC7 (Figure 5B), supporting the existence of specific miRNAs, regulated by HDAC7, that target FABP5. Next,
the authors used an in silico approach to identify miRNAs validated or predicted to target FABP5. After this first
selection, to isolate miRNAs regulated by HDAC7, the loci containing these miRNAs were evaluated for increased
levels of H3K27ac in cells knocked out of HDAC7. Finally, to understand which of the different miRNAs were
directly regulated by HDAC7, the authors also evaluated the different loci for the presence of HDAC7 peaks using
the ChIP-seq data. After these filtering steps, only hsa-miR-21 met all requisites, whereas hsa-miR-218 showed some
HDAC7 binding, but H3K27ac levels were very low and remained unperturbed after HDAC7 deletion (Figure 5C).
As controls, the authors included two miRNAs predicted to target FABP5 (hsa-miR-144 and hsa-miR-202), but
without evidence of HDAC7 binding, as well as increased H3K27ac levels in an HDAC7-dependent manner.
Subsequently, the authors evaluated whether the expression levels of these miRNAs were effectively regulated by
HDAC7. Figure 5D shows that, as expected from the in silico analysis, hsa-miR-21 expression was repressed by
HDAC7. Surprisingly, despite the fact that HDAC7 did not influence H3K27ac levels at the hsa-miR-218 locus, its
expression was clearly increased in MCF10A/HDAC7−/− cells. Next, the authors examined whether hsa-miR-21
and hsa-miR-218 affected FABP5 mRNA levels. Only transfection of the hsa-miR-218 mimic was able to reduce
FABP5 expression to some extent (Figure 5E). In the mammosphere assay, hsa-miR-218 dramatically reduced the
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Figure 4. HDAC7 can influence expression levels of CRABP2 and FABP5. (A) Heat map indicating mRNA fold changes
between HDAC7−/− and HDAC7+/+ MCF10A cells and HDAC7 −/−ER and HDAC7 −/−HDAC7-ER MCF10A cells of genes
involved in RXRA activity. (B) The mRNA expression levels of CRABP2 and FABP5, as measured by qRT-PCR, in
HDAC7−/− and HDAC7+/+ MCF10A cells. (C) The mRNA expression ratio for CRABP2 and FABP5, as measured by
qRT-PCR, in HDAC7−/− and HDAC7+/+ MCF10A cells. (D) Immunoblot analysis of CRABP2 and FABP5 levels in HDAC7
−/−, HDAC7+/+ and HDAC7−/− MCF10A cells re-expressing HDAC7-ER. Cellular lysates were generated and
immunoblots performed with the indicated antibodies. GAPDH was used as loading control. (E) HDAC7−/− and
HDAC7+/+ MCF10A cells were grown for 72 h in the presence of the indicated siRNAs. After cell lysis, mRNA
expression levels of FABP5, IGFBP6 and IGFBP7 were measured by quantitative real-time PCR. (F) Immunoblot analysis
of FABP5 levels in HDAC7+/+ and HDAC7−/− MCF10A cells transfected with RNAi against FABP5 or control RNAi.
Cellular lysates were generated and immunoblots performed with the anti-FABP5 antibody. The anti-GAPDH antibody
was used as loading control. (G) Representative phase contrast images of mammospheres generated by HDAC7+/+
and HDAC7−/− MCF10A cells transfected with RNAi against FABP5 or control RNAi after 5 days in culture (n = 3). (H)
Scatter dot plot illustrating the number of mammospheres generated by HDAC7+/+ and HDAC7−/− MCF10A cells
transfected with RNAi against FABP5 or control RNAi after 5 days in culture (n = 3). (I) Scatter dot plot illustrating the
dimension of mammospheres generated by HDAC7+/+ and HDAC7−/− MCF10A cells transfected with RNAi against
FABP5 or control RNAi after 5 days in culture (n = 3).
*p < 0.05; **p < 0.01; ***p < 0.005.






































































































































Chr17: 59836000–59846000 MIR21 locus H3K27ac
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Figure 5. Translational regulation of FABP5 expression. (A) Detailed view of H3K27ac and HDAC7 tracks at the
FABP5 locus in HDAC7−/− and HDAC7+/+ MCF10A cells. Gene structure and chromosomal location are shown, with
the blue box highlighting differences in the enriched peaks between the two cell lines. (B) Bar graphs showing the
results of luciferase assays in HDAC7+/+ and HDAC7−/− MCF10A cells transfected for 48 h with pGL3 control or pGL3
containing the 3′UTR FABP5. Renilla sp luciferase was used as internal control (n = 3). (C) Detailed view of H3K27ac
and HDAC7 tracks at the indicated miRNA loci in HDAC7−/− and HDAC7+/+ MCF10A cells. Gene structure and
chromosomal location are shown, with the blue box highlighting differences in the enriched peaks between the two
cell lines. (D) Expression level rates between HDAC7−/− and HDAC7+/+ MCF10A cells of the indicated miRNAs, as
measured by quantitative real-time PCR. (E) The mRNA expression levels of GAPDH and FABP5, as measured by
quantitative real-time PCR, in MCF10A cells transfected with miR-21 and miR-218 mimics or scramble control (n = 3).
(F) Scatter dot plot illustrating the number of mammospheres generated by MCF10A cells transfected with miR-21
and miR-218 mimics or scramble control after 5 days in culture (n = 3).
*p < 0.05; **p < 0.01; ***p < 0.005.
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number of spheres, whereas hsa-miR-21 increased their number (Figure 5F). In conclusion, hsa-miR-218 could be
involved in the regulation of FABP5 expression and mammosphere formation in MCF10A cells.
Discussion
The role of HDAC7 in controlling the stemness of both normal and cancer cells has been reported by different
studies [7–9,36,37]. By contrast, the mechanisms and genes that are supervised by HDAC7 for the regulation
of stemness features are less defined. It is possible that different signaling pathways under HDAC7 regulation
converge in the regulation of stemness properties. The authors have recently shown that a consistent pool of genes
repressed by HDAC7 encode for secreted and plasma membrane proteins [9]. In particular, these genes include
inflammatory and antiproliferative cytokines and mediators of the immune response. This specific milieu of factors
could be particularly critical to sustaining or repressing the growth of stem-like cells [6].
Here the authors provide evidence that elements of IGF signaling can also be repressed by HDAC7. In partic-
ular, the authors have found that AKT is less phosphorylated in response to IGF1 when HDAC7 is deleted. The
expression of IGFBP6 and IGFBP7, which encode for proteins that can buffer IGF signaling [26,38], is repressed
by HDAC7. Therefore, it is plausible that the increase in IGFBP6/7 observed in MCF10A/HDAC7−/− cells is
responsible for reduced IGF1 activity. To underline the importance of IGF1 signaling in stemness, the authors have
demonstrated that recombinant IGF1 increases mammosphere formation in MCF10A cells. In agreement with the
authors’ observation, a similar result was recently obtained using MCF10A cells expressing constitutively activated
IGF1R [39]. In cells knocked out for HDAC7, IGF1 was less efficient in generating mammospheres compared
with WT cells. This result confirms that other mechanisms controlling mammosphere formation are under the
regulation of HDAC7. These additional mechanisms could involve the regulation of stemness genes through the
modulation of superenhancers [10].
HDAC7 does not bind directly to DNA; instead, it assembles into multiprotein complexes, which include
DNA-binding TFs. Among them, the family of MEF2 TFs are important partners of HDAC7. However, in
MCF10A cells, IGFPB6 and IGFPB7 are not direct targets of MEF2s [9]. The control of IGF1 signaling by class
IIa HDACs is not a novel concept [40,41]. However, the mechanism involved in this regulation has never been
investigated in detail. By using an unbiased motif-based discovery strategy, the authors have found that RXRA and
FOXA1 could be involved in the upregulation of IGFPB6 and IGFPB7 observed in MCF10A/HDAC7−/− cells.
RNAi experiments excluded FOXA1 and established that the upregulation of IGFBP6 and IGFBP7 observed in
MCF10A/HDAC7−/− cells was mediated by RXRA. A previous study indicated that RXR isoforms could regulate
IGFBP6 expression in breast cancer cells in response to synthetic rexinoid bexarotene [42]. In addition, the authors’
data represent the first report linking RXRA to the control of IGFBP7 expression. Interestingly, IGFBP7 could
represent a common target of different signaling pathways in sustaining stem cell features. In this respect, the role
of IGFBP7 as an inhibitor of the expansion and aggressiveness of tumor stem-like cells was recently demonstrated
in vivo [27].
The repression exerted by HDAC7 on these IGFBPs seemed to exclude direct binding to RXRA. We suggest
that the effect could be indirect and may involve control of CRABP2 and FABP5 expression through the action of
HDAC7. These genes belong to a family of cellular atRA transporters that shepherd the poorly aqueous soluble
retinoids during uptake, metabolism and function [35]. CRABP2 and FABP5 compete for atRA, delivering it to
RARs and PPARbeta/delta, respectively [43,44]. HDAC7 is required to sustain higher levels of FABP5, thus favoring
PPARbeta/delta transcriptional activities with respect to RXRA. Therefore, in the absence of HDAC7, the delivery
of atRA to RXRA should be prevalent. This resetting could be responsible for the upregulation of IGFBP6 and
IGFBP7 expression.
The dramatic downregulation of FABP5 expression after HDAC7 deletion did not involve overt H3K27ac
modifications at its promoter. Instead, the stability of the 3′UTR FABP5 was compromised in the absence
of HDAC7. The miRNAs that targeted FABP5 and were under the repressive influence of HDAC7 could be
responsible for its degradation. A few miRNAs have been characterized for their ability to target FABP5. These
include hsa-mir-21 and hsa-mir-144 [45,46]. The authors have shown that hsa-mir-21 and, expecially, hsa-mir-218
are upregulated after deletion of HDAC7. However, only hsa-mir-218 is able to repress FABP5 and mammosphere
generation. It is very likely that other miRNAs under the regulation of HDAC7 are involved in the control of
FABP5 expression. Further studies are needed for their identification and characterization.
FABP5 is an important target of HDAC7 in the regulation of stemness in MCF10A cells. FABP5 can control
IGFBP6/7 mRNA levels, thus sustaining the authors’ proposed regulatory axis in which HDAC7 affects RXRA
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and IGFBP6/7 transcription by controlling FABP5 mRNA stability, possibly through hsa-mir-218 and additional
miRNAs, to maintain IGF1 signaling and stem cell properties. Clearly, further experiments are necessary to








































Figure 6. The regulative circuit linking HDAC7 to IGFBP6 and IGFBP7 expression. (A) In the presence of HDAC7
mir-218 expression is silences, FABP5 is expressed at high level and IGFBP6/7 levels reduced. (B) Removal of HDAC7
unregulated mir-218 expression in absence of overt variations in H327ac levels. FABP5 mRNA levels decrease with the
up regulation, RXRA-mediated, of IGFBP6/7 and down regulation of IGF1 signaling.
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Conclusion
We have investigated a new regulative circuit supervised by HDAC7 that can repress the transcription of IGFBP6
and IGFBP7. This circuit can promote IGF1 signaling and stemness properties. A representative schema of the
circuit is shown in Figure 6. Our results sustain the view of HDAC7 and class IIa HDACs in general as pleiotropic
epigenetic regulators that influence the expression of several genes in a context-dependent manner.
Future perspective
Studies on the contribution of HDAC7 to the regulation of stemness properties are still in their infancy. Our
results add a new piece to the complex puzzle represented by the regulative circuits supervised by HDAC7 in the
control of gene expression. There are still several open questions that deserve further investigation. For example, it
is unclear through which partners, in addition to MEF2 TFs, HDAC7 acts to control gene expression. Similarly,
the subunits of the super-repressive complex engaged by HDAC7 to control stemness must be identified as well as
the post-transcriptional modifications that control HDAC7 activity.
Summary points
• HDAC7 controls H3K27ac levels in the regulative regions and expression of IRS2, IGFBP6 and IGFBP7.
• IGF1 sustains mammosphere formation.
• In the absence of HDAC7, RXRA promotes IGFBP6 and IGFBP7 expression.
• HDAC7 counteracts RXRA activity indirectly by allowing high levels of FABP5 mRNA and protein.
• The action of HDAC7 on FABP5 mRNA levels is indirect and could be mediated by hsa-mir-218.
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